Effects of COVID-19 Infection on Pregnancy Outcomes and Offspring Health
NCT ID: NCT06186947
Last Updated: 2024-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2022-09-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corona Virus Disease 2019 Cohort Study
NCT06927622
COVID-19 Infection and Fetal-neonatal Outcomes
NCT04699578
Covid-19 Infection in Pregnancy
NCT04869202
Impact of COVID-19 on Pregnancy Outcomes: a Systematic Review
NCT06677281
Obstetric and Perinatal Outcomes of Women With COVID-19
NCT04369859
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will:
1. Undergo a questionnaire to gather details on COVID-19 infection history.
2. Provide data about reproductive history.
3. Be invited for physical examination, laboratory tests and ultrasound scans.
4. Undergo a long-term follow up for pregnancy outcome and offspring health.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 group
Patients infected by SARS CoV2 before reproductive events.
No intervention
Participants are not subjected to any specific intervention.
Control group
Patients who were not infected by SARS CoV2 before reproductive events.
No intervention
Participants are not subjected to any specific intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Participants are not subjected to any specific intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with signed informed consent.
3. Patients with complete COVID-19 infection information.
Exclusion Criteria
2. Recipients of oocyte donation.
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shandong University of Traditional Chinese Medicine
OTHER
The Second Hospital of Shandong University
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Yantai Yuhuangding Hospital Affiliated to Qingdao University
UNKNOWN
Yantai City Yantai Mountain Hospital
UNKNOWN
the First People's Hospital of Jining
UNKNOWN
Weifang People's Hospital
OTHER
Jining Medical University
OTHER
Linyi People's Hospital
OTHER
Dezhou People's Hospital
OTHER
The Affiliated Hospital of Binzhou Medical College
UNKNOWN
Liaocheng People's Hospital
OTHER
The Second People's Hospital of Liaocheng
UNKNOWN
Linyi Maternal and Child Healthcare Hospital
UNKNOWN
Heze Hospital of Traditional Chinese Medicine
UNKNOWN
Weihai maternal and child health care hospital
UNKNOWN
Weifang Maternal and Child Health Hospital
UNKNOWN
Tai'an City Central Hospital
UNKNOWN
Zibo Maternal and Child Health Care Hospital
UNKNOWN
Qingdao Women and Children's Hospital
UNKNOWN
The Affiliated Hospital of Shandong University of Traditional Chinese Medicine
UNKNOWN
Qilu Hospital of Shandong University
OTHER
The Affiliated Hospital of Weifang Medical College
UNKNOWN
Maternal and Child Health Care Hospital of Shandong Province
UNKNOWN
Ren Ji Hospital of Shanghai Jiao Tong University
UNKNOWN
Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chen Zi-Jiang
Academician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zi-Jiang Chen
Role: STUDY_CHAIR
Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Women, Children and Reproductive Health
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVREP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.